RAMM Pharma
RAMM Pharma Corp. is a publicly traded cannabinoid pharmacology company headquartered in Toronto, Canada, that develops and distributes cannabis-based pharmaceutical and hemp products through European subsidiaries Canapar Corp. in Italy and HemPoland in Poland.
- Company typePublic
- Founded1987
- HeadquartersToronto, Canada
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
RAMM Pharma firmographics
Firmographics- Name
- RAMM Pharma
- Legal name
- Ramm Pharma Corp.
- Website
- https://rammpharma.com
- Company type
- Public
- Founded year
- 1987
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- RAMM Pharma Corp. is a publicly traded cannabinoid pharmacology company headquartered in Toronto, Canada, that develops and distributes cannabis-based pharmaceutical and hemp products through European subsidiaries Canapar Corp. in Italy and HemPoland in Poland.
- Ownership category
- akta.pro rank
RAMM Pharma industry classification
Industry- Product category
- Cannabinoid Pharmaceuticals
- NAICS
- Medicinal and Botanical Manufacturing (325411), Pharmaceutical and Medicine Manufacturing (32541)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- CBD/Hemp Wellness & Supplements Retail (CRANAHAC)
- akta.pro secondary industries
- CBD/Hemp Specialty Stores (Tinctures, Oils, Edibles) (CRANAHAA), Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)
Keywords
Where RAMM Pharma is headquartered
LocationHeadquarters
- HQ city
- Toronto
- HQ country
- Canada
- HQ region
- North America
Markets served
RAMM Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
RAMM Pharma product offering
Product offeringCore offering
RAMM Pharma is a cannabinoid pharmacology and product formulation company that develops and distributes cannabis-based pharmaceuticals and hemp-derived products. Through its wholly-owned subsidiaries HemPoland (Poland) and Canapar Corp. (Italy), the company manufactures and distributes CBD products and operates hemp oil extraction technologies across European markets.
Differentiator
Problem solved
Functional benefit
Products and services
- CBD products
- European hemp products
- Cannabinoid pharmaceuticals
Companies that use RAMM Pharma
Customer profileSegments1 record
Ideal customer profiles2 records
RAMM Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
RAMM Pharma partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- The Global South S.A.S.coreRAMM Pharma Corp. received minority shareholder approval for a US$5 million investment in The Global South S.A.S. The transaction includes plans to potentially increase ownership to 25% based on future valuation. The deal is pending regulatory approval and is part of RAMM's expansion strategy into cannabinoid pharmaceuticals and hemp products.
- Canapar Corp.coreRAMM Pharma is acquiring Canapar Corp., a fully integrated European cannabis company based in Italy. The acquisition involves issuing approximately 21.9 million RAMM shares worth about $26.2 million. Canapar is positioned to become one of Europe's largest CBD companies.
Scale indicators4 records
RAMM Pharma competitors and assessment
Company assessmentMarket position
Customer concentration
RAMM Pharma social profiles
Digital presenceRAMM Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
RAMM Pharma leadership team
Management profileNumber of profiles
RAMM Pharma subsidiaries and ownership
Company hierarchySubsidiaries3 records
RAMM Pharma funding detail
Funding detailFunding overview
Funding rounds2 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
RAMM Pharma M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about RAMM Pharma
What does RAMM Pharma do?
RAMM Pharma is a cannabinoid pharmacology and product formulation company that develops and distributes cannabis-based pharmaceuticals and hemp-derived products. Through its wholly-owned subsidiaries HemPoland (Poland) and Canapar Corp. (Italy), the company manufactures and distributes CBD products and operates hemp oil extraction technologies across European markets.
Is RAMM Pharma a public or private company?
RAMM Pharma is a public company. It is classified as public and is currently operating.
When was RAMM Pharma founded?
RAMM Pharma was founded in 1987. It employs 51 to 100 people.
Where is RAMM Pharma based?
RAMM Pharma is headquartered in Toronto, Canada, in the North America region.
Does RAMM Pharma have an API?
No public API is recorded for RAMM Pharma.
What industry is RAMM Pharma in?
RAMM Pharma's product category is Cannabinoid Pharmaceuticals. Its primary akta.pro industry code is CRANAHAC, CBD/Hemp Wellness & Supplements Retail, with a secondary code of CRANAHAA, CBD/Hemp Specialty Stores (Tinctures, Oils, Edibles). Its NAICS code is 325411 and its SIC code is 2833.